A biotech executive developing an experimental fentanyl vaccine says the United States has been fighting the overdose epidemic backwards for years, and he’s calling on the incoming Democratic-controlled Congress to treat synthetic drugs as a biodefense threat rather than a purely criminal justice problem.
Collin Gage, CEO of ARMR Sciences, told Fox News Digital that the country’s reliance on reversing overdoses after they happen misses the point. “If you look at the overdose crisis like any other health crisis, really as a disease, you’ll know the best way to treat a crisis is by preventing it altogether,” Gage said. “We need to completely overhaul the treatment paradigm and focus on preventing these deaths with new innovative therapeutics, rather than continuing the same approach that historically has led to tens of thousands of deaths, hundreds of thousands of deaths over the last several years.”
Gage credited President Donald Trump’s designation of illicit fentanyl as a weapon of mass destruction as “absolutely critical” in pushing Washington toward treating synthetic drugs as a national biodefense priority.
Why fentanyl is a different kind of threat
Gage argues that synthetic drugs like fentanyl, carfentanil, nitazenes and medetomidine behave unlike conventional chemical or biological weapons because they can be produced quickly by virtually anyone with access to the dark web.
“People often don’t realize this, but fentanyl, carfentanil, nitazenes, medetomidine—all of these emerging synthetic drug threats are unique biothreats in that they’re not like sarin gas, they’re not like anthrax,” Gage said. “You can’t go on the dark web and quickly formulate those substances. You can do that with these pharmaceutical-based agents that have completely caused havoc within the United States, and we’re now starting to see that spread globally.”
A vaccine still in early trials
ARMR Sciences is currently running a Phase 1/2 clinical trial testing the safety of its experimental fentanyl vaccine and evaluating how well it blocks synthetic opioids from reaching the brain, rather than waiting until after an overdose has begun to intervene.
“We want our first responders to be as effective as they possibly can in the field,” Gage said.
Gage is pressing the newly seated Democratic majority in Congress to approach the issue as a “red, white and blue” cause rather than a partisan one, pointing out that fentanyl “does not discriminate” based on race or income. He said any expansion of vaccine access beyond military use—including to higher-risk groups such as college students—must be preceded by rigorous safety review and transparency.
The company publishes its full vaccine formulation on its website and deliberately excluded heavy metals, a decision Gage linked to Health and Human Services Secretary Robert F. Kennedy Jr.’s scrutiny of pharmaceutical ingredients. Gage also praised former Rep. Patrick Kennedy’s work on reforming addiction treatment facilities.
A personal stake
Gage’s push is rooted in personal loss. His mother struggled with addiction, and he has lost friends to overdoses.
“Passion is born from internal suffering,” Gage said. “No family should look over and see an empty chair at the dinner table. No kid should be hiding in their room because they’re scared if a parent is suffering from an addiction issue. I want to prevent that happening from any American across the country.”
Anyone struggling with substance use can reach the Substance Abuse and Mental Health Services Administration’s National Helpline 24/7 at 1-800-662-4357.


Add comment